Savara Inc. has grown revenue −14% a year over three years. Revenue growth, 3-year annual rate: −14% (Biotechnology median +17%). Years of annual history on file: 29, FY1997 to FY2025, as filed.

SVRASavara Inc.

Healthcare

$4.93+40% 1Y

$4.93

$3.3752 weeks$6.94

Is it growing?

Is SVRA growing?

Savara Inc. has grown revenue −14% a year over three years.

−14%

Revenue growth, 3-year annual rate · Biotechnology median +17% · shrinking · compounded from fiscal-year columns as filed

Years of annual history on file: 29
Years of annual history on file · FY1997 to FY2025, as filed

Annual income statements as filed with the SEC.

On our screens:Most shorted stocks

Biotechnology

Ranks #96 of 196 by RyuScore

Compare peers

ORIC-0.08%

Oric Pharmaceuticals, Inc.

Hemab Therapeutics Holdings, Inc.

IMTX+0.61%

Immatics N.V.

JBIO+1.9%

Jade Biosciences, Inc.